πŸ‡ΊπŸ‡Έ FDA
Patent

US 6459003

Ether compounds

expired A61PA61P1/18A61P13/12

Quick answer

US patent 6459003 (Ether compounds) held by Esperion Therapeutics, Inc. expires Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Esperion Therapeutics, Inc.
Grant date
Tue Oct 01 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61P, A61P1/18, A61P13/12, A61P15/10, A61P25/28